SREBF1 and metabolic dysfunction-associated steatohepatitis: Nrf2-KO mice are, indeed, more susceptible to developing NASH when submitted to a WD protocol through enhancement of protein levels of SREBP-1c, of which its activity has been related to the activation of lipid synthesis metabolism and impairment of lipid oxidation mechanisms [49,50,51].